Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies

References

• Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32:593-604; PMID:20510870; http://dx.doi.org/10.1016/j.immuni.2010.05.007
   PubMed Web of Science ®Google Scholar
• Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11:889-96; PMID:20856220; http://dx.doi.org/10.1038/ni.1937
   PubMed Web of Science ®Google Scholar
• Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. ScientificWorldJournal 2011; 11:2391-402; PMID:22194670; http://dx.doi.org/10.1100/2011/213962
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25:677-86; PMID:15530839; http://dx.doi.org/10.1016/j.it.2004.09.015
   PubMed Web of Science ®Google Scholar
• Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8:958-69; PMID:19029990; http://dx.doi.org/10.1038/nri2448
   PubMed Web of Science ®Google Scholar
• Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011; 22:317-26; PMID:21289217; http://dx.doi.org/10.1681/ASN.2009060615
   PubMed Web of Science ®Google Scholar
• Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11:723-37; PMID:21997792; http://dx.doi.org/10.1038/nri3073
   PubMed Web of Science ®Google Scholar
• Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Muller W, Roers A, Eming SA. Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010; 184:3964-77; PMID:20176743; http://dx.doi.org/10.4049/jimmunol.0903356
   PubMed Web of Science ®Google Scholar
• Cardilo-Reis L, Gruber S, Schreier SM, Drechsler M, Papac-Milicevic N, Weber C, Wagner O, Stangl H, Soehnlein O, Binder CJ. Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. EMBO Mol Med 2012; 4:1072-86; PMID:23027612; http://dx.doi.org/10.1002/emmm.201201374
   PubMed Web of Science ®Google Scholar
• Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013; 339:172-7; PMID:23307735; http://dx.doi.org/10.1126/science.1230721
   PubMed Web of Science ®Google Scholar
• Liu C, Li Y, Yu J, Feng L, Hou S, Liu Y, Guo M, Xie Y, Meng J, Zhang H, et al. Targeting the shift from m1 to m2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil. PLoS One 2013; 8:13; PMID:23418431
   PubMed Web of Science ®Google Scholar
• Orme J, Mohan C. Macrophage subpopulations in systemic lupus erythematosus. Discov Med 2012; 13:151-8; PMID:22369974
   PubMedGoogle Scholar
• Crielaard BJ, Lammers T, Morgan ME, Chaabane L, Carboni S, Greco B, Zaratin P, Kraneveld AD, Storm G. Macrophages and liposomes in inflammatory disease: friends or foes? Int J Pharmac 2011; 416:499-506; PMID:21238559; http://dx.doi.org/10.1016/j.ijpharm.2010.12.045
   PubMed Web of Science ®Google Scholar
• Goren I, Muller E, Schiefelbein D, Christen U, Pfeilschifter J, Muhl H, Frank S. Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 2007; 127:2259-67; PMID:17460730; http://dx.doi.org/10.1038/sj.jid.5700842
   PubMed Web of Science ®Google Scholar
• Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, Hainzl A, Schatz S, Qi Y, Schlecht A, et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 2011; 121:985-97; PMID:21317534; http://dx.doi.org/10.1172/JCI44490
   PubMed Web of Science ®Google Scholar
• Thepen T, Langeveld-Wildschut EG, Bihari IC, van Wichen DF, van Reijsen FC, Mudde GC, Bruijnzeel-Koomen CA. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996; 97:828-37; PMID:8613640; http://dx.doi.org/10.1016/S0091-6749(96)80161-8
   PubMed Web of Science ®Google Scholar
• Bruhns P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood 2012; 119:5640-9; PMID:22535666; http://dx.doi.org/10.1182/blood-2012-01-380121
   PubMed Web of Science ®Google Scholar
• Heijnen IA, Van de Winkel JG. A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeutics. J Hematother 1995; 4:351-6; PMID:8581368; http://dx.doi.org/10.1089/scd.1.1995.4.351
   PubMedGoogle Scholar
• Thepen T, van Vuuren AJ, Kiekens RC, Damen CA, Vooijs WC, van De Winkel JG. Resolution of cutaneous inflammation after local elimination of macrophages. Nat Biotechnol 2000; 18:48-51; PMID:10625390; http://dx.doi.org/10.1038/71908
   PubMed Web of Science ®Google Scholar
• Hristodorov D, Mladenov R, Huhn M, Barth S, Thepen T. Macrophage-targeted therapy: CD64-based immunotoxins for treatment of chronic inflammatory diseases. Toxins 2012; 4:676-94; PMID:23105975; http://dx.doi.org/10.3390/toxins4090676
   PubMedGoogle Scholar
• Ribbert T, Thepen T, Tur MK, Fischer R, Huhn M, Barth S. Recombinant, ETA'-based CD64 immunotoxins: improved efficacy by increased valency, both in vitro and in vivo in a chronic cutaneous inflammation model in human CD64 transgenic mice. Br J Dermatol 2010; 163:279-86; PMID:20426788; http://dx.doi.org/10.1111/j.1365-2133.2010.09824.x
   PubMed Web of Science ®Google Scholar
• Schiffer S, Letzian S, Jost E, Mladenov R, Hristodorov D, Huhn M, Fischer R, Barth S, Thepen T. Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells. Cancer Lett 2013; 341:178-85; PMID:23973499; http://dx.doi.org/10.1016/j.canlet.2013.08.005
   PubMed Web of Science ®Google Scholar
• Schiffer S, Rosinke R, Jost E, Hehmann-Titt G, Huhn M, Melmer G, Barth S, Thepen T. Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins. Int J Cancer 2014; PMID:24523193
   PubMed Web of Science ®Google Scholar
• Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140:871-82; PMID:20303877; http://dx.doi.org/10.1016/j.cell.2010.02.029
   PubMed Web of Science ®Google Scholar
• Hetzel C, Bachran C, Fischer R, Fuchs H, Barth S, Stocker M. Small cleavable adapters enhance the specific cytotoxicity of a humanized immunotoxin directed against CD64-positive cells. J Immunother 2008; 31:370-6; PMID:18391759; http://dx.doi.org/10.1097/CJI.0b013e31816a2d23
   PubMed Web of Science ®Google Scholar
• Stahnke B, Thepen T, Stocker M, Rosinke R, Jost E, Fischer R, Tur MK, Barth S. Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes. Mol Cancer Ther 2008; 7:2924-32; PMID:18790773; http://dx.doi.org/10.1158/1535-7163.MCT-08-0554
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23:549-55; PMID:12401408; http://dx.doi.org/10.1016/S1471-4906(02)02302-5
   PubMed Web of Science ®Google Scholar
• Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27:451-83; PMID:19105661; http://dx.doi.org/10.1146/annurev.immunol.021908.132532
   PubMed Web of Science ®Google Scholar
• van Rooijen N, van Nieuwmegen R, Kamperdijk EW. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. Ultrastructural aspects of elimination of marginal zone macrophages. Virchows Archiv B Cell Pathol Includ Mol Pathol 1985; 49:375-83; PMID:2867636; http://dx.doi.org/10.1007/BF02912114
   PubMedGoogle Scholar
• Thepen T, Van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 1989; 170:499-509; PMID:2526847; http://dx.doi.org/10.1084/jem.170.2.499
   PubMed Web of Science ®Google Scholar
• Nieuwenhuijzen GA, Haskel Y, Lu Q, Berg RD, van Rooijen N, Goris RJ, Deitch EA. Macrophage elimination increases bacterial translocation and gut-origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation. Ann Surge 1993; 218:791-9; PMID:8257230; http://dx.doi.org/10.1097/00000658-199312000-00014
   PubMed Web of Science ®Google Scholar
• Kotter MR, Setzu A, Sim FJ, Van Rooijen N, Franklin RJ. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 2001; 35:204-12; PMID:11494411; http://dx.doi.org/10.1002/glia.1085
   PubMed Web of Science ®Google Scholar
• Borders AS, Getchell ML, Etscheidt JT, van Rooijen N, Cohen DA, Getchell TV. Macrophage depletion in the murine olfactory epithelium leads to increased neuronal death and decreased neurogenesis. J Compar Neurol 2007; 501:206-18; PMID:17226772; http://dx.doi.org/10.1002/cne.21252
   PubMed Web of Science ®Google Scholar
• van Amerongen MJ, Harmsen MC, van Rooijen N, Petersen AH, van Luyn MJ. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 2007; 170:818-29; PMID:17322368; http://dx.doi.org/10.2353/ajpath.2007.060547
   PubMed Web of Science ®Google Scholar
• Bannon P, Wood S, Restivo T, Campbell L, Hardman MJ, Mace KA. Diabetes induces stable intrinsic changes to myeloid cells that contribute to chronic inflammation during wound healing. Dis Models Mech 2013; PMID:24057002
   PubMed Web of Science ®Google Scholar
• Li J, Hsu HC, Mountz JD. The dynamic duo-inflammatory M1 macrophages and Th17 cells in rheumatic DISEASES. J Orthop Rheumatol 2013; 1:4; PMID:25309946; http://dx.doi.org/10.13188/2334-2846.1000002
   PubMedGoogle Scholar
• Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991; 9:457-92; PMID:1910686; http://dx.doi.org/10.1146/annurev.iy.09.040191.002325
   PubMed Web of Science ®Google Scholar
• Daeron M. Fc receptor biology. Annu Rev Immunol 1997; 15:203-34; PMID:9143687; http://dx.doi.org/10.1146/annurev.immunol.15.1.203
   PubMed Web of Science ®Google Scholar
• Kiekens RC, Thepen T, Bihari IC, Knol EF, Van De Winkel JG, Bruijnzeel-Koomen CA. Expression of Fc receptors for IgG during acute and chronic cutaneous inflammation in atopic dermatitis. Br J Dermatol 2000; 142:1106-13; PMID:10848732; http://dx.doi.org/10.1046/j.1365-2133.2000.03534.x
   PubMed Web of Science ®Google Scholar
• Balce DR, Li B, Allan ER, Rybicka JM, Krohn RM, Yates RM. Alternative activation of macrophages by IL-4 enhances the proteolytic capacity of their phagosomes through synergistic mechanisms. Blood 2011; 118:4199-208; PMID:21846901; http://dx.doi.org/10.1182/blood-2011-01-328906
   PubMed Web of Science ®Google Scholar
• Yates RM, Hermetter A, Taylor GA, Russell DG. Macrophage activation downregulates the degradative capacity of the phagosome. Traffic 2007; 8:241-50; PMID:17319801; http://dx.doi.org/10.1111/j.1600-0854.2006.00528.x
   PubMed Web of Science ®Google Scholar
• Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood 2008; 112:935-45; PMID:18684880; http://dx.doi.org/10.1182/blood-2007-12-077917
   PubMed Web of Science ®Google Scholar
• Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5:953-64; PMID:16322748; http://dx.doi.org/10.1038/nri1733
   PubMed Web of Science ®Google Scholar
• Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229:176-85; PMID:23096265; http://dx.doi.org/10.1002/path.4133
   PubMed Web of Science ®Google Scholar
• Bystrom J, Evans I, Newson J, Stables M, Toor I, van Rooijen N, Crawford M, Colville-Nash P, Farrow S, Gilroy DW. Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 2008; 112:4117-27; PMID:18779392; http://dx.doi.org/10.1182/blood-2007-12-129767
   PubMed Web of Science ®Google Scholar
• Biswas SK, Mantovani A. Orchestration of metabolism by macrophages. Cell Metab 2012; 15:432-7; PMID:22482726; http://dx.doi.org/10.1016/j.cmet.2011.11.013
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 2005; 201:1355-9; PMID:15867089; http://dx.doi.org/10.1084/jem.20050640
   PubMed Web of Science ®Google Scholar
• Dalrymple H, Barna BP, Malur A, Malur AG, Kavuru MS, Thomassen MJ. Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes. BMC Immunol 2013; 14:1471-2172; http://dx.doi.org/10.1186/1471-2172-14-41
   Web of Science ®Google Scholar
• Reinartz S, Schumann T, Finkernagel F, Wortmann A, Jansen JM, Meissner W, Krause M, Schwörer AM, Wagner U, Müller-Brüsselbach S, et al. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer 2014; 134:32-42; PMID:23784932; http://dx.doi.org/10.1002/ijc.28335
   PubMed Web of Science ®Google Scholar
• Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, De Nardo D, Gohel TD, Emde M, Schmidleithner L, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014; 40:274-88; PMID:24530056; http://dx.doi.org/10.1016/j.immuni.2014.01.006
   PubMed Web of Science ®Google Scholar
• Homeyer A, Schenk A, Arlt J, Dahmen U, Dirsch O, Hahn HK. Practical quantification of necrosis in histological whole-slide images. Comput Med Imaging Graph 2013; 37:313-22; PMID:23796718; http://dx.doi.org/10.1016/j.compmedimag.2013.05.002
   PubMed Web of Science ®Google Scholar
• Huhn M, Sasse S, Tur MK, Matthey B, Schinkothe T, Rybak SM, Barth S, Engert A. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma. Cancer Res 2001; 61:8737-42; PMID:11751393
   PubMed Web of Science ®Google Scholar